[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,761,261
  • Shares Outstanding, K 45,497
  • Annual Sales, $ 1,334 M
  • Annual Income, $ 97,310 K
  • EBIT $ 288 M
  • EBITDA $ 405 M
  • 60-Month Beta 0.52
  • Price/Sales 3.08
  • Price/Cash Flow 11.91
  • Price/Book 4.90

Options Overview Details

View History
  • Implied Volatility 37.17% (-0.12%)
  • Historical Volatility 49.16%
  • IV Percentile 18%
  • IV Rank 28.30%
  • IV High 72.27% on 10/21/25
  • IV Low 23.32% on 03/17/26
  • Expected Move (DTE 1) 3.47 (3.20%)
  • Put/Call Vol Ratio 0.54
  • Today's Volume 233
  • Volume Avg (30-Day) 116
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 4,384
  • Open Int (30-Day) 3,286
  • Expected Range 104.94 to 111.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.31
  • Number of Estimates 6
  • High Estimate $1.37
  • Low Estimate $1.25
  • Prior Year $1.27
  • Growth Rate Est. (year over year) +3.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.95 +44.64%
on 07/23/26
108.50 -0.08%
on 08/19/26
+30.55 (+39.24%)
since 07/17/26
3-Month
55.75 +94.46%
on 05/20/26
108.50 -0.08%
on 08/19/26
+51.56 (+90.69%)
since 05/19/26
52-Week
47.31 +129.12%
on 09/26/25
108.50 -0.08%
on 08/19/26
+54.11 (+99.65%)
since 08/19/25

Most Recent Stories

More News
1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid

1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid

HAE : 108.41 (+3.59%)
THC : 268.52 (-0.63%)
HCAT : 1.6900 (-1.17%)
5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call

5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call

HAE : 108.41 (+3.59%)
HAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady

HAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady

HAE : 108.41 (+3.59%)
Haemonetics (NYSE:HAE) Beats Q2 CY2026 Sales Expectations

Haemonetics (NYSE:HAE) Beats Q2 CY2026 Sales Expectations

HAE : 108.41 (+3.59%)
Haemonetics: Fiscal Q1 Earnings Snapshot

Haemonetics: Fiscal Q1 Earnings Snapshot

HAE : 108.41 (+3.59%)
Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

Financial release and supplemental presentation accessible online

HAE : 108.41 (+3.59%)
Haemonetics: Can Hospital Growth Justify the Plasma Business Stall?

Barchart Research What to Expect from HAE Earnings HAE Generated August 5, 2026 Current Price $83.60 EPS Estimate $$1.07 Consensus Rating Moderate Buy Average Move 12.81% Haemonetics: Can Hospital Growth...

HAE : 108.41 (+3.59%)
What To Expect From Haemonetics’s (HAE) Q2 Earnings

What To Expect From Haemonetics’s (HAE) Q2 Earnings

HAE : 108.41 (+3.59%)
New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

BOSTON , Aug. 3, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 108.41 (+3.59%)
Martin Madaus Elected to Haemonetics Board of Directors

BOSTON , July 28, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes,...

HAE : 108.41 (+3.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 113.09
2nd Resistance Point 110.80
1st Resistance Point 109.60
Last Price 108.41
1st Support Level 106.11
2nd Support Level 103.82
3rd Support Level 102.62

See More

52-Week High 108.50
Last Price 108.41
Fibonacci 61.8% 85.13
Fibonacci 50% 77.91
Fibonacci 38.2% 70.69
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.